PRESS RELEASE published on 04/30/2025 at 22:25, 1 year ago Wellgistics Health Reports Strong Q1 Operational Growth Across Manufacturer, Product, and Pharmacy Expansion with Over 350 New Pharmacies Added to Its Nationwide Network Wellgistics Health, Inc. announces key operational highlights for Q1 2025, reflecting growth in independent pharmacies, pharmaceutical manufacturers, and prescription drug products Healthcare Technology Operational Highlights Q1 2025 Wellgistics Health Pharmaceutical Services
BRIEF published on 04/24/2025 at 13:45, 1 year ago Wellgistics nomme Mark DiSiena au poste de directeur financier Directeur Financier Croissance Stratégique Rendez-vous Wellgistics Santé Mark DiSiena
BRIEF published on 04/24/2025 at 13:45, 1 year ago Wellgistics Appoints Mark DiSiena as CFO CFO Appointment Strategic Growth Wellgistics Health Mark DiSiena
PRESS RELEASE published on 04/24/2025 at 13:40, 1 year ago Wellgistics Names Mark DiSiena as New CFO Wellgistics Health, Inc. appoints Mark DiSiena as new CFO to lead strategic growth initiatives in healthcare technology and pharmaceutical services. DiSiena brings over 30 years of experience in finance and leadership roles at various companies Healthcare Technology CFO Wellgistics Health Pharmaceutical Services Mark DiSiena
BRIEF published on 04/15/2025 at 13:45, 1 year 1 month ago Wellgistics Health Converts $1.5 Million Debt to Equity Healthcare Technology Strategic Direction Debt To Equity Wellgistics Health IPO Price
BRIEF published on 04/15/2025 at 13:45, 1 year 1 month ago Wellgistics Health convertit 1,5 million de dollars de dettes en capitaux propres Technologie De La Santé Orientation Stratégique Wellgistics Santé Dette Par Rapport Aux Capitaux Propres Prix D'introduction En Bourse
PRESS RELEASE published on 04/15/2025 at 13:40, 1 year 1 month ago CEO of Wellgistics Health Converts $1.5 Million of Debt to Equity at IPO Price Wellgistics Health, Inc. converts $1.5M debt to shares of common stock, reinforcing CEO's commitment to long-term shareholder value. Newly issued shares subject to 12-month lock-up agreement Shareholder Value Common Stock Debt Conversion Wellgistics Health Inc. CEO Commitment
BRIEF published on 04/10/2025 at 13:45, 1 year 1 month ago Wellgistics Health acquiert Peek Healthcare pour améliorer ses services de prescription Acquisition Technologie De La Santé Peek Healthcare Wellgistics Santé Transparence Des Ordonnances
BRIEF published on 04/10/2025 at 13:45, 1 year 1 month ago Wellgistics Health Acquires Peek Healthcare to Enhance Prescription Services Acquisition Healthcare Technology Wellgistics Health Peek Healthcare Prescription Transparency
PRESS RELEASE published on 04/10/2025 at 13:40, 1 year 1 month ago Wellgistics Health, Inc. Announces Agreement to Acquire Peek Healthcare Technologies, Inc., to Support Over 2,500 Patients and $1.5MM Annual Revenue Wellgistics Health, Inc. (NASDAQ:WGRX) announces acquisition of Peek Healthcare Technologies, Inc. to enhance digital prescription shopping platform and improve medication pricing transparency for consumers Acquisition Digital Prescription Wellgistics Health Peek Healthcare Technologies Medication Pricing Transparency
Published on 05/16/2026 at 01:15, 2 days 1 hour ago Findev Inc. Announces a New Member of the Board of Directors
Published on 05/16/2026 at 00:00, 2 days 2 hours ago Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate
Published on 05/15/2026 at 23:10, 2 days 3 hours ago Golden Minerals Reports First Quarter 2026 Financial Results
Published on 05/16/2026 at 16:08, 1 day 10 hours ago The publication of the audited financial statements for 2025 will be postponed to 12 June 2026 – management does not expect any significant changes to the figures already published
Published on 05/15/2026 at 20:10, 2 days 6 hours ago CPIPG Communication Concerning Voluntary Offer on NEXT RE Shares – Provisional Results Announcement
Published on 05/15/2026 at 18:10, 2 days 8 hours ago Virtual Science AI launches first AI-driven competitor activity tracking platform to support pharma asset launch success
Published on 05/15/2026 at 15:08, 2 days 11 hours ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010203026
Published on 05/15/2026 at 15:00, 2 days 11 hours ago Exercice de l’option de remboursement de l'instrument subordonné FR0010203026
Published on 05/15/2026 at 10:09, 2 days 16 hours ago Groupe Crit : Modalités de mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 05 juin 2026.
Published on 05/14/2026 at 09:03, 3 days 17 hours ago Coup d'envoi pour les carrières dans l'esport : 65% de la population mondiale réclame plus de formations et de parcours professionnels pour le jeu vidéo de compétition
Published on 05/13/2026 at 18:02, 4 days 8 hours ago ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES